Meakins defends his review
Meakins defends his review
Jonathan Meakins, a surgeon at Royal Victoria Hospital in Montreal, followed the presentation of Alpha-Beta Technology Inc.'s Phase I/II study of Betafectin last week with comments that became a focus of controversy surrounding the company's management of the trial.
In